Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma

Conditions: Nasopharyngeal Carcinoma Interventions: Drug: Sintilimab, bevacizumab, gemcitabine; Radiation: IMRT Sponsors: Zhejiang Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials